Abiopharma

News list

Tanimoto William Joseph 🟡 adjusted position in 0 shares (1 derivative) of TERAWULF INC. (WULF) Transaction Date: Aug 16, 2026 | Filing ID: 000169

Full text

News bot Aug. 17, 2026, 10:11 p.m.
🔍 Tanimoto William Joseph (Executive)

Company: TERAWULF INC. (WULF)

Report Date: 2026-08-16
Transaction Summary:
- Total transactions: 2
- Derivative instruments: 1
- Holdings reported: 0
- Total shares acquired: 6,666
- Total shares sold: 6,666
Detailed Transactions and Holdings:
- Acquired 6,666 shares of Common stock, $0.001 par value per share (Direct)
  Date: 2026-08-16 | Code: M | equity_swap_involved: 0 | shares_owned_after: 55,564.00 | transaction_form_type: 4 | Footnotes: F1
- Sold 6,666 shares of Restricted Stock Units (Derivative)
  Date: 2026-08-16 | Code: M | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F2, F3, F3, F3
Footnotes:
- F1: The Reporting Person received Restricted Stock Units which vested in accordance with their terms upon the third anniversary of August 16, 2023, as reported in this Form 4, subject to the Reporting Person's continued employment or service with the Issuer through such date.
- F2: Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock, $0.001 par value per share.
- F3: The restricted stock units vested in accordance with their terms upon the third anniversary of August 16, 2023, subject to the Reporting Person's continued employment or service with the Issuer through each such date.